249 related articles for article (PubMed ID: 25299784)
1. Inhibition of phosphotidylinositol-3 kinase pathway by a novel naphthol derivative of betulinic acid induces cell cycle arrest and apoptosis in cancer cells of different origin.
Majeed R; Hamid A; Sangwan PL; Chinthakindi PK; Koul S; Rayees S; Singh G; Mondhe DM; Mintoo MJ; Singh SK; Rath SK; Saxena AK
Cell Death Dis; 2014 Oct; 5(10):e1459. PubMed ID: 25299784
[TBL] [Abstract][Full Text] [Related]
2. PI3K target based novel cyano derivative of betulinic acid induces its signalling inhibition by down-regulation of pGSK3β and cyclin D1 and potentially checks cancer cell proliferation.
Majeed R; Hussain A; Sangwan PL; Chinthakindi PK; Khan I; Sharma PR; Koul S; Saxena AK; Hamid A
Mol Carcinog; 2016 May; 55(5):964-76. PubMed ID: 26013878
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of 3-O-propargylated betulinic acid and its 1,2,3-triazoles as potential apoptotic agents.
Majeed R; Sangwan PL; Chinthakindi PK; Khan I; Dangroo NA; Thota N; Hamid A; Sharma PR; Saxena AK; Koul S
Eur J Med Chem; 2013 May; 63():782-92. PubMed ID: 23584541
[TBL] [Abstract][Full Text] [Related]
4. Betulinic acid induces apoptosis by regulating PI3K/Akt signaling and mitochondrial pathways in human cervical cancer cells.
Xu T; Pang Q; Wang Y; Yan X
Int J Mol Med; 2017 Dec; 40(6):1669-1678. PubMed ID: 29039440
[TBL] [Abstract][Full Text] [Related]
5. A novel triazole derivative of betulinic acid induces extrinsic and intrinsic apoptosis in human leukemia HL-60 cells.
Khan I; Guru SK; Rath SK; Chinthakindi PK; Singh B; Koul S; Bhushan S; Sangwan PL
Eur J Med Chem; 2016 Jan; 108():104-116. PubMed ID: 26629862
[TBL] [Abstract][Full Text] [Related]
6. Betulinic Acid Restricts Human Bladder Cancer Cell Proliferation In Vitro by Inducing Caspase-Dependent Cell Death and Cell Cycle Arrest, and Decreasing Metastatic Potential.
Kim SY; Hwangbo H; Kim MY; Ji SY; Kim DH; Lee H; Kim GY; Moon SK; Leem SH; Yun SJ; Kim WJ; Cheong J; Park C; Choi YH
Molecules; 2021 Mar; 26(5):. PubMed ID: 33806566
[TBL] [Abstract][Full Text] [Related]
7. Betulinic Acid Inhibits Cell Proliferation in Human Oral Squamous Cell Carcinoma via Modulating ROS-Regulated p53 Signaling.
Shen H; Liu L; Yang Y; Xun W; Wei K; Zeng G
Oncol Res; 2017 Aug; 25(7):1141-1152. PubMed ID: 28109089
[TBL] [Abstract][Full Text] [Related]
8. Betulinic acid chemosensitizes breast cancer by triggering ER stress-mediated apoptosis by directly targeting GRP78.
Cai Y; Zheng Y; Gu J; Wang S; Wang N; Yang B; Zhang F; Wang D; Fu W; Wang Z
Cell Death Dis; 2018 May; 9(6):636. PubMed ID: 29802332
[TBL] [Abstract][Full Text] [Related]
9. Induction of cell cycle arrest and apoptosis by betulinic acid-rich fraction from Dillenia suffruticosa root in MCF-7 cells involved p53/p21 and mitochondrial signalling pathway.
Foo JB; Saiful Yazan L; Tor YS; Wibowo A; Ismail N; How CW; Armania N; Loh SP; Ismail IS; Cheah YK; Abdullah R
J Ethnopharmacol; 2015 May; 166():270-8. PubMed ID: 25797115
[TBL] [Abstract][Full Text] [Related]
10. Betulinic acid induces apoptosis and inhibits metastasis of human renal carcinoma cells in vitro and in vivo.
Yang C; Li Y; Fu L; Jiang T; Meng F
J Cell Biochem; 2018 Nov; 119(10):8611-8622. PubMed ID: 29923216
[TBL] [Abstract][Full Text] [Related]
11. Betulinic acid decreases ER-negative breast cancer cell growth in vitro and in vivo: role of Sp transcription factors and microRNA-27a:ZBTB10.
Mertens-Talcott SU; Noratto GD; Li X; Angel-Morales G; Bertoldi MC; Safe S
Mol Carcinog; 2013 Aug; 52(8):591-602. PubMed ID: 22407812
[TBL] [Abstract][Full Text] [Related]
12. 3-O-(E)-p-Coumaroyl betulinic acid possess anticancer activity and inhibit Notch signaling pathway in breast cancer cells and mammosphere.
Kushwaha PP; Singh AK; Shuaib M; Prajapati KS; Vardhan PS; Gupta S; Kumar S
Chem Biol Interact; 2020 Sep; 328():109200. PubMed ID: 32702347
[TBL] [Abstract][Full Text] [Related]
13. PARP cleavage and perturbance in mitochondrial membrane potential by 3-α-propionyloxy-β-boswellic acid results in cancer cell death and tumor regression in murine models.
Qurishi Y; Hamid A; Sharma PR; Wani ZA; Mondhe DM; Singh SK; Zargar MA; Andotra SS; Shah BA; Taneja SC; Saxena AK
Future Oncol; 2012 Jul; 8(7):867-81. PubMed ID: 22830406
[TBL] [Abstract][Full Text] [Related]
14. Development and evaluation of long-circulating nanoparticles loaded with betulinic acid for improved anti-tumor efficacy.
Saneja A; Kumar R; Singh A; Dhar Dubey R; Mintoo MJ; Singh G; Mondhe DM; Panda AK; Gupta PN
Int J Pharm; 2017 Oct; 531(1):153-166. PubMed ID: 28823888
[TBL] [Abstract][Full Text] [Related]
15. Betulinic Acid-Mediated Apoptosis in Human Prostate Cancer Cells Involves p53 and Nuclear Factor-Kappa B (NF-κB) Pathways.
Shankar E; Zhang A; Franco D; Gupta S
Molecules; 2017 Feb; 22(2):. PubMed ID: 28208611
[TBL] [Abstract][Full Text] [Related]
16. Betulinic acid induces apoptosis and inhibits metastasis of human colorectal cancer cells in vitro and in vivo.
Zeng A; Hua H; Liu L; Zhao J
Bioorg Med Chem; 2019 Jun; 27(12):2546-2552. PubMed ID: 30910472
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological evaluation of a novel betulinic acid derivative as an inducer of apoptosis in human colon carcinoma cells (HT-29).
Chakraborty B; Dutta D; Mukherjee S; Das S; Maiti NC; Das P; Chowdhury C
Eur J Med Chem; 2015 Sep; 102():93-105. PubMed ID: 26248310
[TBL] [Abstract][Full Text] [Related]
18. Betulinic acid inhibits the proliferation of human laryngeal carcinoma cells through reactive oxygen species-mediate mitochondrial apoptotic pathway.
Zhang H; Zhou M; Ye C; Qin J; Lu X; Wang C; Wang X; Jin X
Toxicol In Vitro; 2024 Mar; 95():105756. PubMed ID: 38061603
[TBL] [Abstract][Full Text] [Related]
19. Betulinic acid decreases expression of bcl-2 and cyclin D1, inhibits proliferation, migration and induces apoptosis in cancer cells.
Rzeski W; Stepulak A; Szymański M; Sifringer M; Kaczor J; Wejksza K; Zdzisińska B; Kandefer-Szerszeń M
Naunyn Schmiedebergs Arch Pharmacol; 2006 Oct; 374(1):11-20. PubMed ID: 16964520
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, characterization and augmented anticancer potential of PEG-betulinic acid conjugate.
Saneja A; Sharma L; Dubey RD; Mintoo MJ; Singh A; Kumar A; Sangwan PL; Tasaduq SA; Singh G; Mondhe DM; Gupta PN
Mater Sci Eng C Mater Biol Appl; 2017 Apr; 73():616-626. PubMed ID: 28183653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
